347 related articles for article (PubMed ID: 25899052)
41. In vitro trypanocidal activity of dibutyltin dichloride and its fatty acid derivatives.
Shuaibu MN; Kanbara H; Yanagi T; Ichinose A; Ameh DA; Bonire JJ; Nok AJ
Parasitol Res; 2003 Sep; 91(1):5-11. PubMed ID: 12851812
[TBL] [Abstract][Full Text] [Related]
42. A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding.
DeJesus E; Kieft R; Albright B; Stephens NA; Hajduk SL
PLoS Pathog; 2013; 9(4):e1003317. PubMed ID: 23637606
[TBL] [Abstract][Full Text] [Related]
43. The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense.
Radwanska M; Chamekh M; Vanhamme L; Claes F; Magez S; Magnus E; de Baetselier P; Büscher P; Pays E
Am J Trop Med Hyg; 2002 Dec; 67(6):684-90. PubMed ID: 12518862
[TBL] [Abstract][Full Text] [Related]
44. Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1.
Sharma AK; Friedman DJ; Pollak MR; Alper SL
FEBS J; 2016 May; 283(10):1846-62. PubMed ID: 26945671
[TBL] [Abstract][Full Text] [Related]
45. The human serum resistance associated gene is ubiquitous and conserved in Trypanosoma brucei rhodesiense throughout East Africa.
Gibson W; Backhouse T; Griffiths A
Infect Genet Evol; 2002 May; 1(3):207-14. PubMed ID: 12798017
[TBL] [Abstract][Full Text] [Related]
46. Human innate immunity against African trypanosomes.
Pays E; Vanhollebeke B
Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
[TBL] [Abstract][Full Text] [Related]
47. Detection of T.b. rhodesiense trypanosomes in humans and domestic animals in south east Uganda by amplification of serum resistance-associated gene.
Enyaru JC; Matovu E; Nerima B; Akol M; Sebikali C
Ann N Y Acad Sci; 2006 Oct; 1081():311-9. PubMed ID: 17135530
[TBL] [Abstract][Full Text] [Related]
48. Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense. 1949.
Tobie EJ; von Brand T; Mehiman B
J Parasitol; 2001 Aug; 87(4):714-7. PubMed ID: 11534630
[TBL] [Abstract][Full Text] [Related]
49. Characterization and grouping of Trypanosoma brucei brucei, T.b. gambiense and T.b. rhodesiense by quantitative DNA-cytofluorometry and discriminant analysis.
Mühlpfordt H; Berger J
Trop Med Parasitol; 1989 Mar; 40(1):1-8. PubMed ID: 2544979
[TBL] [Abstract][Full Text] [Related]
50. Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance.
Symula RE; Beadell JS; Sistrom M; Agbebakun K; Balmer O; Gibson W; Aksoy S; Caccone A
PLoS Negl Trop Dis; 2012; 6(7):e1728. PubMed ID: 22802982
[TBL] [Abstract][Full Text] [Related]
51. Human serum resistance of metacyclic forms of Trypanosoma brucei brucei, T. brucei rhodesiense and T. brucei gambiense.
Brun R; Jenni L
Parasitol Res; 1987; 73(3):218-23. PubMed ID: 3588581
[TBL] [Abstract][Full Text] [Related]
52. Activity of human trypanosome lytic factor in mice.
Barker C; Barbour KW; Berger FG; Hajduk SL
Mol Biochem Parasitol; 2001 Oct; 117(2):129-36. PubMed ID: 11606222
[TBL] [Abstract][Full Text] [Related]
53. The molecular arms race between African trypanosomes and humans.
Pays E; Vanhollebeke B; Uzureau P; Lecordier L; Pérez-Morga D
Nat Rev Microbiol; 2014 Aug; 12(8):575-84. PubMed ID: 24975321
[TBL] [Abstract][Full Text] [Related]
54. Identification of Trypanosoma brucei components involved in trypanolysis by normal human serum.
Lecordier L; Uzureau P; Tebabi P; Pérez-Morga D; Nolan D; Schumann Burkard G; Roditi I; Pays E
Mol Microbiol; 2014 Nov; 94(3):625-36. PubMed ID: 25256834
[TBL] [Abstract][Full Text] [Related]
55. [The controversial story of the human trypanolytic factor].
Pays E; Vanhollebeke B
Med Sci (Paris); 2008 Oct; 24(10):792-3. PubMed ID: 18950568
[No Abstract] [Full Text] [Related]
56. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
Picozzi K; Carrington M; Welburn SC
Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
[TBL] [Abstract][Full Text] [Related]
57. Sleeping sickness in Uganda: a thin line between two fatal diseases.
Picozzi K; Fèvre EM; Odiit M; Carrington M; Eisler MC; Maudlin I; Welburn SC
BMJ; 2005 Nov; 331(7527):1238-41. PubMed ID: 16308383
[TBL] [Abstract][Full Text] [Related]
58. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum.
Smith AB; Hajduk SL
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10262-6. PubMed ID: 7479764
[TBL] [Abstract][Full Text] [Related]
59. Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene.
Welburn SC; Picozzi K; Fèvre EM; Coleman PG; Odiit M; Carrington M; Maudlin I
Lancet; 2001 Dec; 358(9298):2017-9. PubMed ID: 11755607
[TBL] [Abstract][Full Text] [Related]
60. Sleeping sickness: a tale of two diseases.
Welburn SC; Fèvre EM; Coleman PG; Odiit M; Maudlin I
Trends Parasitol; 2001 Jan; 17(1):19-24. PubMed ID: 11137736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
